Is Ascendis Pharma A/S (ASND) a Buy, Sell, or Hold?
NASDAQ : ASND
Ascendis Pharma A/S — Stock Grades
$245.5105 USD
$0.92 (0.38%)
- Volume
- 176.76K
- Average Volume
- 692.06K
- Market Capitalization
- $15.25B
- P/E Ratio
- 25.94
- Dividend Yield
- 0.00%
- Price Target
- $277.50
- Year High
- $282.15
- Year Low
- $175.19
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.00
ASND Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-07-23 | Morgan Stanley | Overweight | Overweight | Maintain |
| 2026-07-07 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-05-15 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-05-11 | Barclays | Overweight | Overweight | Maintain |
| 2026-05-08 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-04-16 | B of A Securities | Buy | Buy | Maintain |
| 2026-04-09 | Wedbush | Outperform | Outperform | Maintain |
| 2026-03-03 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-02-12 | Wedbush | Outperform | Outperform | Maintain |
| 2026-02-12 | Oppenheimer | Outperform | Outperform | Maintain |
| 2026-01-30 | B of A Securities | Buy | Buy | Maintain |
| 2026-01-20 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-01-20 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-01-09 | Wells Fargo | Overweight | Overweight | Maintain |
| 2026-01-07 | TD Cowen | Buy | Buy | Maintain |